EVENTS

Joint Pharmacy and Dental Education Sessions

Speakers: Caroline Barraclough and Thomas O’Connor

Dates:

• 14th October 2024: Antimicrobial use and prescribing for dental use 7pm-9pm
• 21st October 2024: CPPE Anticoagulants and MRONJ workshop 7pm-8:30pm
• 28th October 2024: Analgesic prescribing in dentistry 7pm-9pm
• 4th November 2024: Prescribing for dental conditions: dental and pharmacy professionals supporting people 7pm-9pm

Delivery Method: Online via Microsoft Teams and or Zoom (Invites will be sent out one week before the session)

Open To: Dentists and DCPs

Maximum Spaces: 30

Cost: Dentists: £10.00 DCP: £5.00

Key Information

Are you interested in learning with other healthcare professionals? Would you like to know more about considerations to anticoagulant use in dental procedures or how medicines can cause osteonecrosis of the jaw and how to work across the system on a range of prescribing areas?

This dental /pharmacy education provision is a series of linked workshops open to both dental and pharmacy professionals. The series of 4 evening workshops starts on Monday 14th October 2024 and runs each Monday evening for 4 consecutive weeks.

Each workshop is open to a mix of pharmacy and dental colleagues to promote interdisciplinary conversations and better practice.

Invites to the online session will be sent out the week before the session. A welcome email to the course will be sent out one month before the first session.

If you have any questions beforehand please do not hesitate to get in touch. Please contact dental.administrator@esneft.nhs.uk with any questions or queries.

Course Aims:

These 4 sessions will support dental and pharmacy professionals to identify how to work together to promote:  

1. Effective antibiotic stewardship
2. Appropriate analgesia
3. Correct use of the more obscure items available on dental prescribing
4. Awareness of interactions and side effects (eg steroids, anticoagulants, MRONJ).
   
   The workshops will enable general dental practitioners and pharmacy professionals to work as part of a multidisciplinary team to support patients with their dental treatment. These sessions will support dental and pharmacy professionals to identify how to work together to promote effective antibiotic stewardship and support people with urgent dental conditions.

Course Objectives: 

1. Review antimicrobial resistance, why it is important and national strategies to reduce the risk of antimicrobial resistant infections. The impact of antimicrobial resistant infections and the effect that the COVID - 19 pandemic has had on dental antibiotic prescribing will be analysed.
2. Interactively explore urgent dental conditions and workshop appropriate management techniques from the dentists' and the pharmacists' perspectives. Engage the candidates in strategies for utilising the full range of options available for dental prescribing, including correct use of the less commonly prescribed medications.
3. Evaluate practical approaches to a multidisciplinary approach between the dentist and pharmacist to support and optimize prescribing for dental conditions.
4. Explain antimicrobial resistance, why it is important, and national strategies to reduce the risk of antimicrobial resistant infections.
5. Guide the learner to recognise urgent dental conditions and discuss appropriate management techniques.

Learning Outcomes: 

Following this course you will be able to: 

1. Implement changes in your own prescribing practice to reduce antimicrobial resistance and the impact of antibiotic resistant infections.
2. Justify appropriate management techniques in urgent dental conditions and evaluate when to use antibiotics in line with national guidelines.
3. Create and implement a multidisciplinary approach (pharmacist / dentist) to support and optimize prescribing for dental conditions. Evaluate how anticoagulants are used in practice and how they affect patients’ dental treatment. 
4. Assess how medicines can cause medication-related osteonecrosis of the jaw (MRONJ) and plan suitable adjustments in patients’ dental treatment. Empower joint decision-making for patients in the options for  treatment and the monitoring required while taking medicines that can cause MRONJ. 

GDC Learning Outcomes: 

• C
• D